Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead

NCT07273656 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT07273656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07273656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Lead sponsor
University Hospital, Lille
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2028
Enrollment
59 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses, keratosis